COAST: Modelling Restenosis and Stent Based Therapies

被引:0
|
作者
Evans, D. J. W. [1 ]
Caiazzo, A. [3 ]
Falcone, J. L. [4 ]
Hegewald, J. [5 ]
Lorenz, E. [6 ]
Stahl, B. [4 ]
Wang, D. [7 ]
Bernsdorf, J. [7 ]
Chopard, B. [4 ]
Gunn, J. [1 ]
Walker, D. [2 ]
Hose, R. [1 ]
Krafczyk, M. [5 ]
Hoekstra, A. [6 ]
Lawford, P. [1 ]
机构
[1] Univ Sheffield, Med Phys Grp, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England
[3] INRIA Rocquencourt, Paris, France
[4] Univ Geneva, CUI Dept, Geneva, Switzerland
[5] Tech Univ Carolo Wilhelmina Braunschweig, Inst Comp Appl Civil Engn, Braunschweig, Germany
[6] Univ Amsterdam, Computat Sci, Amsterdam, Netherlands
[7] NEC Europe Ltd, NEC Labs Europe, St Augustin, Germany
关键词
Restenosis; Stent; Complex Automata; Coupling; Multiscale; COMPLEX AUTOMATA; CORONARY-ARTERY; CELLS;
D O I
10.1007/978-3-642-04292-8_71
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
COAST (Complex Automata Simulation Technique) is a European Union FP6 funded project which has developed a methodology for multi-science, multi-scale simulation of complex systems. The resulting framework (MUSCLE: Multiscale Simulation Coupling Library and Environment is now publically available. As an exemplar, MUSCLE has been applied to the model of a complex biomedical pathology, that of in-stent restenosis, resulting in a hierarchical aggregation of coupled cellular automata and agent based models coined "complex automaton". Currently, three simple, single scale models have been coupled to simulate the pathological response of the arterial wall to stent-deployment: an agent based model of smooth muscle cell dynamics (modeling cell cycle and cell-cell interaction), a lattice Boltzmann model of blood flow (defining wall shear stress and oscillatory shear index at the vessel surface) and a finite difference drug diffusion model (defining stent-eluted drug concentrations across the vessel wall). These sub-models operate on distinct temporal scales and can be plotted on a scale separation map. This conceptual tool defines the temporal separation of the processes and the coupling template required for interaction between them PI. Coupling is implemented using smart conduits and in some situations, mapper agents, which transfer information between models with lattice based domains (blood flow, drug diffusion) to those with continuous domains (smooth muscle behaviour). Here we present preliminary output of a simple 2D model of in-stent restenosis. The present model captures the relationship between degree of stent induced injury and the smooth muscle cell hyperplastic response. The generation of realistic output correlates well with experimental data and paves the way for computer-aided design of stent-based therapies.
引用
收藏
页码:319 / +
页数:2
相关论文
共 50 条
  • [21] In stent restenosis - benign or dangerous? Clinical presentation of in-stent restenosis in Sweden
    Omerovic, E.
    Ramunddal, T.
    Matejka, G.
    Albertsson, P.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 : 271 - 271
  • [22] Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis
    Kim, Young-Hak
    Lee, Bong-Ki
    Park, Duk-Woo
    Park, Kyoung-Ha
    Choi, Bong-Ryong
    Lee, Cheol Whan
    Hong, Myeong-Ki
    Kim, Jae-Joong
    Park, Seong-Wook
    Park, Seung-Jung
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (11): : 1451 - 1454
  • [23] Uncertainty quantification of a three-dimensional in-stent restenosis model with surrogate modelling
    Ye, Dongwei
    Zun, Pavel
    Krzhizhanovskaya, Valeria
    Hoekstra, Alfons G.
    [J]. JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2022, 19 (187)
  • [24] α-lipoic acid inhibits stent restenosis in a porcine coronary stent restenosis model.
    Kim, JH
    Jeong, MH
    Hong, YJ
    Kim, KH
    Kim, W
    Ahn, YK
    Cho, JG
    Park, JC
    Kang, JC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8B): : 57D - 57D
  • [25] Late Restenosis of Sirolimus-eluting Stent in the Treatment of In-stent Restenosis of Sirolimus-eluting Stent
    Shibayama, Kentaro
    Kadota, Kazushige
    Tsujimoto, Yuki
    Saito, Naoki
    Miyamoto, Masakazu
    Otsuru, Suguru
    Okamoto, Yoji
    Imai, Masao
    Tasaka, Hiroshi
    Hasegawa, Daiji
    Shigemoto, Yoshikazu
    Habara, Seiji
    Tanaka, Hiroyuki
    Maruo, Takeshi
    Hirono, Akitoshi
    Nishibori, Yosiharu
    Hosogi, Shingo
    Fuku, Yasushi
    Oka, Naoki
    Katoh, Hurumi
    Yamamoto, Hiroyuki
    Fujii, Satoki
    Goto, Tsuyoshi
    Inoue, Katsumi
    Mitsudo, Kazuaki
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 161D - 161D
  • [26] A Novel Stent Based Gene Delivery System for the Prevention of Restenosis
    Fishbein, Ilia
    Alferiev, Ivan S.
    Foster, Jonathan B.
    Guerrero, David T.
    Monteys, Alejandro Mas
    Chorny, Michael
    Levy, Robert J.
    [J]. CIRCULATION, 2016, 134
  • [27] Dealing with in-stent restenosis
    Gershlick, AH
    Baron, J
    [J]. HEART, 1998, 79 (04) : 319 - 323
  • [28] Predictors of in-stent restenosis
    Hoffmann, R
    Shiran, A
    Ezibe, MM
    Oljaca, B
    Slack, S
    Pappas, C
    Williams, M
    Mintz, GS
    [J]. CIRCULATION, 1997, 96 (08) : 2292 - 2292
  • [29] Inflammation and In-Stent Restenosis
    Demirtas, Koray
    [J]. ANGIOLOGY, 2018, 69 (01) : 89 - 89
  • [30] Devices for in-stent restenosis
    Henney, JE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (01): : 34 - 34